This CPB has been updated, for Medicare Part B, to designate Dysport or Xeomin as a preferred brand for cervical dystonia and upper limb spasticity. This CPB has been updated, for Medicare Part B, to remove requirement of Xeomin trial prior to use of Dysport for blepharospasm and chronic sialorrhea.